Combination therapy with proteasome inhibitors and TLR agonists enhances tumour cell death and IL-1β production.

about

Combination therapy with proteasome inhibitors and TLR agonists enhances tumour cell death and IL-1β production.

Item

http://www.wikidata.org/entity/Q48507691

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Combination therapy with prote ...... ll death and IL-1β production.

@en

Combination therapy with prote ...... ll death and IL-1β production.

@nl

type

Item

label

Combination therapy with prote ...... ll death and IL-1β production.

@en

Combination therapy with prote ...... ll death and IL-1β production.

@nl

prefLabel

Combination therapy with prote ...... ll death and IL-1β production.

@en

Combination therapy with prote ...... ll death and IL-1β production.

@nl

P1476

Combination therapy with prote ...... ell death and IL-1β production

@en

P2093

Anthony C Tang

http://www.w3.org/2001/XMLSchema#string

Seyed M Rahavi

http://www.w3.org/2001/XMLSchema#string

P2860

The Yin and Yang of Toll-like receptors in cancer

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL

Why not treat human cancer with interleukin-1 blockade?

A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib.

Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3.

NF-kappa B as a therapeutic target in multiple myeloma.

Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy.

Bortezomib induces nuclear translocation of IκBα resulting in gene-specific suppression of NF-κB--dependent transcription and induction of apoptosis in CTCL.

Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice

P304

162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41419-017-0194-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29415982

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

5833743

http://www.w3.org/2001/XMLSchema#string